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and Roberto AccinniaABSTRACT: Detection and quantification of different aminothiols forms (reduced and total) in biological fluids are important
for the investigation of oxidative stress-related diseases and cell homeostasis study. The aim of this study was to optimize a
HPLC method in order to determine both reduced and total thiol forms in red blood cells (RBC) at low temperature without
washing erythrocytes. Analytical recoveries for total and reduced thiols were 91.6–98.5 and 94.9–98.2% respectively. The
relative standard deviations intra-assay for total and reduced thiols were 1.14–3.64 and 0.83–2.3% respectively and the
relative standard deviations inter-assay for total and reduced thiols were 1.12–3.54 and 0.84–2.03%, respectively. This
method allows specific analysis of the aminothiol state inside the RBC, as a model of intracellular metabolism functioning.
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32Introduction
The redox-state is a critical determinant of cell functions and
homeostasis, and any major imbalances can cause severe
damage or cell death. Various redox active compounds are
implicated in those processes, among them the biological thiols
(SH-) containing amino acids known as aminothiols, which play
numerous physiological roles.
Erythrocytes are rich in protein-SHs and antioxidant enzymes
and have glutathione (GSH)-redox recycling to protect tissues
from prolonged oxidative stress elicited by reactive oxygen
species (Valko et al., 2007). Therefore, thiol compounds in
plasma can be used as an index of a peripheral response of
the organism to external stimuli that may impact on the redox
state, whereas erythrocytes may be a model of the intracellular
response (Valko et al., 2007; Powers and Jackson, 2008).
Characterization of the biochemical profile of the different
forms of aminothiols (reduced and total forms) in biological
fluids may be relevant both in clarifying the mechanisms
underlying the oxidative stress-related diseases and in monitoring
the response to possible drug/food supplement treatments
(Pastore et al., 2003; Camera and Picardo, 2002).
Several chromatographic methods for the determination of
thiols have been described in the literature; however, all of these
methodologies show some disadvantages, such as equipment
costs, complex protocols and sample processing, long run times
and also simultaneous quantification of thiols and/or compli-
cated parameter validation for high-throughput routine clinical
or research purposes. Therefore the choice of method is crucial
to obtain relevant data in a short time. In this paper a method
able to determine reduced and total aminothiols forms was
optimized, in red blood cells (RBC) at low temperature without
erythrocyte washing. This method was applied for the assess-
ment of oxidative stress through thiols measurement in human
plasma and RBC in order to understand the interplay between
the forms of thiols in the different compartments, both in theBiomed. Chromatogr. 2014; 28: 327–331 Copyright © 2013 Johnredox homeostasis maintenance and in the oxidative stress
conditions. The balance among glutathione forms plays a central
role as a hallmark and a potential biomarker of several diseases
(Petrillo et al., 2013; Dhawan et al., 2011; Martín et al., 2004).
Experimental
Chemicals
L-cystine, cysteinylglycine, DL-homocystine, L-glutathione, oxidized and
reduced forms; 4-fluoro-7-sulfamoylbenzofurazan (ABD-F) and Tris-(2-
carboxyethyl)-phosphine hydrochloride (TCEP) were purchased from Sigma
(St. Louis, MO, USA). Methanol, acetic acid, sodium acetate, boric acid,
sodium hydroxide, trichloroacetic acid (TCA) and ethylenediaminetetra
acetic acid (EDTA) were purchased from Merck (Darmstadt, Germany).
Bi-distilled and deionized water (18 MΩ of conductance) were obtained
from Milli Q System, Millipore (Vimodrone, Milan, Italy). All chemicals
were HPLC grade or of the highest purity available.Instrumentations and chromatographic conditions
We used an HPLC pump Varian Pro Star model 240 (Varian, Palo Alto, CA,
USA), coupled to an auto-sampler Varian Pro Star model 410 with a Peltière
temperature control (Varian, Palo Alto, CA, USA) and an FP 1520 Jasco
fluorescence detector with a 150 W xenon lamp (Jasco Europe, Cremella,Wiley & Sons, Ltd.
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328Lecco, Italy). The fluorimetric detector was set at excitation and emission
wavelengths of 390 and 510 nm respectively, and a bandwidth of 18 nm.
Chromatograms were automatically integrated using dedicated software,
Varian STAR Chromatography Workstation (Varian Palo Alto, CA, USA).
Analyte separation was performed on a 5 μm Discovery C18 analytical
column (250×4.6 mm i.d, Supelco, Sigma-Aldrich) at room temperature.
The mobile phases consisted of 0.1 M acetate buffer, pH 4.0–methanol,
81:19 (v/v). Aminothiols were separated over 10 min at a flow rate of
1.0 mL/min. The units of measurement are micromolar.Standard preparation
Individual stock solutions of Cystine (Cys), Cysteineglycine (CysGly),
Homocysteine (Hcy) and Glutathione (GSH) oxidized and reduced forms
were prepared from separate weighs of each compound dissolved in HCl
1 M at 600 μM final concentrations. All individual stock solutions were
stored at 80°C to simulate the storage conditions of physiological sam-
ples. Standard mixes containing all four aminothiols were prepared at
the beginning of each validation experiment by appropriate dilution
with HCl 1 M.Sample pre-treatment
Whole blood was collected by venipuncture into EDTA tubes and plasma
was immediately separated from the cellular portion by centrifugation at
4000g for 2 min at 4°C to prevent thiol oxidation. Immediately after
discarding plasma and the buffy coat, aliquots of RBC were transferred
to test tubes and frozen in liquid nitrogen. Each sample was stored at
80°C until analysis. Immediately before analysis the RBC were thawed,
diluted 1:2 (v/v) with distilled water and re-frozen in liquid nitrogen to
achieve the membrane rupture. For reduced RBC aminothiols the
samples were thawed, diluted 1:2 (v/v) in TCA (100 g/L with 1 mM EDTA)
and centrifuged at 14,000g for 10 min at 4°C before sample preparation.
For total aminothiols, RBC samples or calibration standard curve were
first reduced with TCEP and subsequently diluted 1:2 (v/v) in TCA (100 g/L
with 1 mM EDTA) and centrifuged at 14,000g for 10 min at 4°C before
sample preparation.Figure 1. Representative chromatograms of: standard solution (a) containin
and 30 mM of GSH (peak 4); human plasma total (b) and reduced (c) thiols
Peak 1 was Cys, peak 2 was CysGly, peak 3 was Hcy and peak 4 was GSH. S
in the text. The peak 4 of human RBC is eluted after dilution 1:20 (v/v) with
Copyright © 2013 Johnwileyonlinelibrary.com/journal/bmcSample preparation
To 100 μL of each supernatant obtained were added 10 μL of 0.4 M
NaOH, 70 μL of 1 M borate buffer pH 11 containing 4 mM EDTA, 30 μL
of 1 M borate buffer pH 9.5 containing 4 mM EDTA, and 10 μL of 10 g/L
ABD-F in borate buffer (1 M pH 9.5 containing 4 mM EDTA). Samples were
incubated at 4°C for 90 min and then 10 μL were injected onto the HPLC
system for analysisMethod validation
Method validation was carried out according to the FDA guidelines
(US Food and Drug Administration, 2001) including the linearity, sensitivity,
accuracy, precision, recovery, carryover and stability. For stability the
samples of standard and RBC were stored at 80°C.
Three different whole blood samples were centrifuged at 4000g to
separated the RBC. Then the RBC were subjected to three washing cycles
with saline solution. Before the washings and after each subsequent
single washing, an aliquot of each sample was frozen in order to verify
the variation of thiols concentration during the washing of the RBC.
Results and discussion
Representative chromatograms of standard solutions, human
total and reduced plasma and human total and reduced RBC
from healthy volunteers are depicted in Fig. 1. Retention times
for Cys, CysGly, Hcy and GSH were approximately 5.4, 6.1, 7.1
and 8.6 min, respectively. The peaks of interest were well
separated without interfering compounds. We have reported in
previous work that the presence of internal standard decreases
the accuracy of the analysis, so in this method we did not use
the internal standard (Accinni et al., 1998).
In order to test the linearity of the method we injected
increasing concentration of standard solutions. Ten standard
concentration of different mix oxidized thiols concentrations
ranging from 0.59 to 300 μM for Cys, from 0.12 to 60 μM for
Hcy and from 0.24 to 120 μM for CysGly and GSH were processedg 75 mM of Cys (peak 1). 30mM of CysGly (peak 2), 15mM of Hcy (peak 3)
and human RBC total (d) and reduced (e) thiols from healthy volunteers.
tandard mixture and sample were prepared and analyzed as described
borate buffer pH 9.5. Injection volumes of all sample were 10 μ L.
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Figure 2. Variation of RBC total (⋄) and reduced (▴) thiols concentrations in different washes. Panel A: variations in the RBC Cys concentrations. Panel
B: variations in the RBC CysGly concentrations. Panel C: variations in the RBC Hcy concentrations. Panel D: variations in the RBC GSH concentrations.
Determination of different forms of aminothiols in RBCas described above. The calibration curve for each aminothiol
were obtained by linear regression analysis of the aminothiol
peak area plotted against the nominal aminothiol concentration
expressed in micromolar. For Cys the linearity curve was
y=28,904x+34,559, r=1; for CysGly it was y=133,637x+74,539,
r=0.999; for Hcy it was y=99,109x+10,686, r=1; and for GSH it
was y=88064x+24873, r=1.
For accuracy and precision, pools of RBC were collected and
frozen in liquid nitrogen as described above. Ten replicates of
total and reduced RBC samples were made for two days followed
by analysis of 10 replicates on the third day, for the determination
of inter-day precision. Intra-day precision were instead determined
from n=10 replicate samples on day 3. Inter-assay and intra-assay
coefficients of variation were <4% (Table 1).
Analytical recovery was performed by adding human RBC to
three different concentrations of mix oxidized or reduced forms
standard solution. Samples were treated as described above. Six
replicates unspiked (control) and spiked of total and reduced
RBC samples were analyzed using calibration curves. The recov-
ery was calculated by subtracting the concentration of unspiked
samples from the spiked samples concentration. The value
obtained was divided by the concentration of standard and
multiplied by 100. Measured concentrations were defined as
100%. Means, standard deviations and relative standard
deviations were calculated (Table 2).Table 1. Intra- and inter-day precision for all four aminothiols in
Total aminothiols in RBC
Intra-daya Inter-dayb
μM RSD (%) μM RSD (
Cys 36.29 ± 1.32 3.64 36.32 ± 1.29 3.54
CysGly 5.79 ± 0.07 1.14 5.79 ± 0.06 1.12
Hcy 2.83 ± 0.08 2.91 2.82 ± 0.08 2.75
GSH 1977.3 ± 52.2 2.64 1985.9 ± 44.0 2.22
aTen control replicates on day 3.
bTen replicates for each form for two days followed by analysis of
Biomed. Chromatogr. 2014; 28: 327–331 Copyright © 2013 JohnThe absolute detection limit was determined as three times
the baseline noise level. The samples of standard and RBC were
measured in order to test the stability of the total and reduced
samples for three months and no changes were noted in the
concentration of the samples assayed. The fluorescent adduct
samples was stable for 24 h if stored at 4°C and 48 h if stored
at 20°C (data not shown).
The preservation of the original reduced state in plasma and
especially in RBC appears to be the most delicate step in the
sample preparation after collection. This is due to fast kinetics
of oxidation of SH groups. In fact, during the first hour after
collection, reduced thiols undergo a significant decrease if
stored at room temperature (Anderson et al., 1995) and even if
stored at lower temperatures (data not shown). Also, the
temperature during the formation of fluorescent adducts for
the fluorimetric detection of thiols may play a key role in the
formation of methodological artifacts. In fact, if the reaction
occurs at high temperatures (usually at 60°C) the reduced thiol
forms and the oxidized ones react with each other, generating
mixed disulfides (Santa et al., 2006). Other authors demonstrated
that ABD-F (4-aminosulfonyl-7-fluoro-2,1,3-benzoxadiazole) is a
preferred derivatization reagent for the accurate determination of
the reduced-form thiols in samples containing the oxidized-form
thiols with respect to 7-fluoro-2,1,3-benzoxadiazole-4-sulfonate
(Otani et al., 2011).red blood cells (RBC)
Reduced aminothiols in RBC
Intra-daya Inter-dayb
%) μM RSD (%) μM RSD (%)
3.72 ± 0.09 2.3 3.73 ± 0.07 1.85
0.72 ± 0.01 1.79 0.71 ± 0.01 2.03
0.65 ± 0.01 1.04 0.65 ± 0.01 0.91
1059.7 ± 8.7 0.83 1061.1 ± 9.0 0.84
10 replicates on day 3.
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Table 2. Recovery of all four thiols from human RBC (n= 6)
Concentration (μM)
Total aminothiols in RBC Spiked Measured (mean± SD) % RSD (%)
Cys 43.23 ± 0.60 75.00 117.1 ± 0.6 98.5 ± 0.8 0.9
18.75 61.4 ± 0.2 97.1 ± 1.0 1.0
9.38 52.3 ± 0.2 94.7 ± 1.6 1.6
CysGly 5.57 ± 0.06 30.00 33.39 ± 0.06 92.8 ± 0.19 0.2
7.50 12.7 4 ± 0.06 95.7 ± 0.7 0.8
3.75 9.00 ± 0.02 91.6 ± 0.4 0.5
Hcy 3.02 ± 0.03 15.00 17.73 ± 0.09 98.1 ± 0.6 0.6
3.75 6.70 ± 0.02 98.2 ± 0.6 0.6
1.88 4.9 ± 0.01 98.3 ± 0.6 0.7
GSH 2149.4 ± 1.2 600.00 2739.8 ± 3.5 98.4 ± 0.6 0.6
150.00 2293.5 ± 1.3 96.1 ± 0.9 1.0
75.00 2222.9 ± 6.0 98.1 ± 0.8 0.8
Reduced aminothiols in RBC
Cys 4.17 ± 0.1 75.00 77.8 ± 0.7 98.2 ± 0.9 1.0
18.75 22.3 ± 0.2 96.6 ± 1.0 1.0
9.38 13.4 ± 0.1 98.2 ± 1.3 1.4
CysGly 1.17 ± 0.01 30.00 30.3 ± 0.1 97.2 ± 0.4 0.4
7.50 8.5 ± 0.1 97.1 ± 1.0 1.0
3.75 5.0 ± 0.1 96.5 ± 1.2 1.2
Hcy 1.10 ± 0.05 15.00 15.5 ± 0.1 96.2 ± 0.9 1.0
3.75 4.7 ± 0.02 96.5 ± 0.7 0.7
1.88 2.9 ± 0.04 95.2 ± 2.4 2.5
GSH 1186.4 ± 15.7 600.00 1760.5 ± 7.5 95.7 ± 1.3 1.3
150.00 1328.8 ± 2.1 94.9 ± 1.4 1.5
75.00 1259.1 ± 1.0 96.9 ± 1.4 1.5
Table 3. Mean total and reduced aminothiols in plasma and RBC from 102 healthy volunteers
Cys CysGly Hcy GSH Cys CysGly Hcy GSH
Total aminothiols in plasma (μM) Reduced aminothiols in plasma (μM)
Women 229.8 ± 40.6 34.6 ± 8.3 9.2 ± 2.0 10.9 ± 1.8 9.5 ± 1.7 2.4 ± 0.6 0.16 ± 0.04 2.4 ± 0.6
Men 218.6 ± 45.4 35.3 ± 8.5 10.3 ± 2.3 11.6 ± 2.3 9.5 ± 1.8 2.7 ± 0.6 0.18 ± 0.06 2.3 ± 0.7
All together 224.4 ± 43.1 35.0 ± 8.4 9.7 ± 2.2 11.3 ± 2.1 9.5 ± 1.7 2.55 ± 0.6 0.18 ± 0.05 2.4 ± 0.7
Total aminothiols in RBC (μM) Reduced aminothiols in RBC (μM)
Women 29.5 ± 21.4 4.2 ± 3.6 2.5 ± 1.6 1989.5 ± 715.6 4.7 ± 4.1 0.73 ± 0.58 0.75 ± 0.69 1182.3 ± 534.7
Men 30.6 ± 14.3 5.3 ± 3.3 2.7 ± 1.4 2069.0 ± 707.1 3.4 ± 2.7 0.86 ± 0.56 0.79 ± 0.71 1220.5 ± 548.6
All together 30.1 ± 18.2 4.7 ± 3.5 2.6 ± 1.5 2027.8 ± 709.2 4.1 ± 3.5 0.79 ± 0.57 0.77 ± 0.71 1200.6 ± 539.1
Age 45.9 ± 12.0 (women 46.7 ± 10.7, n= 53; men 45.1 ± 13.2, n= 49) and body mass index 22.7 ± 2.7 (women 22.2 ± 2.6, n=53; men
23.2 ± 2.7, n= 49).
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especially designed to minimize several pitfalls that frequently
influence the determination of those aminothiols with low
concentrations in certain compartments (e.g. Hcy and CysGly
blood concentrations).
To avoid a significant decrease of reduced thiols (Anderson
et al., 1995), in our procedure the blood is immediately centrifuged
at 4°C after collection, to separate the compartments avoiding
exchanges. This protocol allows possible interference in the analy-
sis to be avoided. For the same reason, we did not proceed withCopyright © 2013 Johnwileyonlinelibrary.com/journal/bmcthe washing of the RBC, but immediately collected the RBC after
removing the buffy coat.
Avoiding this step, we can dose aminothiols inside the RBC
without both the plasma interference obtained if we measure
the aminothiols in whole blood, and the important alterations
in the aminothiols pattern that we noticed when the washing
step was applied (Fig. 2A–D). In this way we can analyze
specifically the aminothiol state inside the RBC, as a model of
intracellular metabolism functioning and also in plasma, as
indicators of the peripheral response of the organism.Biomed. Chromatogr. 2014; 28: 327–331Wiley & Sons, Ltd.
Determination of different forms of aminothiols in RBCDifferently from other validated methods, this method can be
used to investigate the relationships between Hcy, Cys, CysGly
and GSH not only in cell but also in plasma. By the described
method, total and reduced aminothiols forms were investigated
in RBC and in the plasma of 102 healthy volunteers. The average
values obtained are shown in Table 3.
This study has been fully validated as a simple, sensitive and
reproducible HPLC method for total and reduced thiols both in
the intracellular compartment (RBC) and extracellular space
(plasma). The method does not utilize an internal standard, as
previously discussed (Accinni et al., 1998), and demonstrates good
RBC and plasma recovery and an excellent sensitivity. It is suitable
for clinical study to support both the monitoring and investigation
of redox interplay between the different forms of aminothiols in
physiological and pathophysiological conditions.
This simple method also allows study of the metabolism of
the different forms of circulating aminothiols as a marker of both
oxidative stress and antioxidative defence capacity. The high
sensitivity of the method can be used to monitor clinical trials
(studies) based on nutritional supplementation to verify the effi-
cacy and antioxidant capacity of many molecules. The method
additionally allows study of the different forms of aminothiols
in the different compartments simultaneously, to discern their
respective roles and to select appropriate therapies.
Acknowledgment
The authors thank Dr Annamaria Tonini for scientific contribu-
tions. This work was supported by Driatec, Cassina de’ Pecchi,
Milan, Italy.
References
Accinni R, Campolo J, Bartesaghi S, De Leo G, Luccarelli C and Parodi O.
High performance liquid chromatography determination of total
plasma homocysteine with or without internal standard. Journal of
Chromatography A 1998; 828: 397–400.Biomed. Chromatogr. 2014; 28: 327–331 Copyright © 2013 JohnAnderson A, Lindgren A and Hultberg B. Effect of thiol oxidation and
thiol export from erythrocytes on determination of redox status of
homocysteine and other thiols in plasma from healty subjects and
patients with cerebral infarction. Clinical Chemistry 1995; 41: 361–366.
Camera E and Picardo M. Analytical methods to investigate glutathione
and related compounds in biological and pathological processes.
Journal of Chromatography B 2002; 781: 181–206.
Dhawan SS, Eshtehardi P, McDaniel MC, Fike LV, Jones DP, Quyyumi AA
and Samady H. The role of plasma aminothiols in the prediction of
coronary microvascular dysfunction and plaque vulnerability.
Atherosclerosis 2011; 219: 266–272.
Martín I, Gibert MJ, Pintos C, Noguera A, Besalduch A and Obrador A.
Oxidative stress in mothers who have conceived fetus with neural
tube defects: the role of aminothiols and selenium. Clinical Nutrition
2004; 23: 507–514.
Otani L, Ogawa S, Zhao Z, Nakazawa K, Umehara S, Yoshimura E, Chang
SJ and Kato H. Optimized method for determinino free L-cysteine in
rat plasma by high performance liquid chromatography with the
4-aminosulfonyl-7-fluoro-2,1,3-bezoxadiazole conversion reagent.
Bioscience, Biotechnology, and Biochemistry 2011; 75: 2119–2124.
Pastore A, Federici G, Bertini E and Piemonte F. Analysis of glutathione:
implication in redox and detoxification. Clinica Chimica Acta 2003;
333: 19–39.
Petrillo S, Piemonte F, Pastore A, Tozzi G, Aiello C, Pujol A, Cappa M and
Bertini E. Glutathione imbalance in patients with X-linked adrenoleu-
kodystrophy. Molecular Genetics and Metabolism 2013; 109: 366–370.
Powers SK and Jackson MJ. Exercise induced oxidative stress: cellular
mechanism and impact on muscle force production. Physiological
Review 2008; 88: 1243–1276.
Santa T, Aoyama C, Fukushima T, Imai K and Funatsu T. Suppression of
thiol exchange reaction in the determination of reduced form thiols
by high performance liquid chromatography with fluorescence
detection after derivatization with fluorogenic benzofurazan reagent,
7-fluoro-2,1,3-benzoxadiazole-4-sulfonate and 4-aminosulfonyl-7-
fluoro-2,1,3-benzoxadiazole. Biomedical Chromatography 2006; 20:
656–661.
US Food and Drug Administration. Guidance for Industry: Bioanalytical
Method Validation. US Department of Health and Human Services,
Food and Drug Administration, Center for Drug Evaluation and
Research: Rockville, MD, 2001.
Valko M, Leibfritz D, Moncola J, Cronin MTD, Mazur M and Telser J. Free
radicals and antioxidants in normal physiological and human disease.
The International Journal of Biochemistry and Cell Biology 2007; 39:
44–84.Wiley & Sons, Ltd. wileyonlinelibrary.com/journal/bmc
331
